Nov 5 (Reuters) – HUTCHMED (China) Ltd: * FDA GRANTS ORPHAN DRUG DESIGNATION TO SOVLEPLENIB FOR AUTOIMMUNE HEMOLYTIC ANEMIA Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)